Article Per Year (5 Year)
p-Index From 2019 - 2024
1.037
P-Index
This Author published in this journals
All Journal Pharmascience JURNAL INSTEK (Informatika Sains dan Teknologi) Jurnal Farmasi Indonesia Jurnal Kajian Ilmiah Kesehatan Dan Teknologi (JKIKT) Jurnal Insan Farmasi Indonesia Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan
Muhammad Zaini
Politeknik Unggulan Kalimantan
Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Computer Science & IT Control & Systems Engineering Electrical & Electronics Engineering Engineering Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Physics Public Health

Published : 9 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : Jurnal Insan Farmasi Indonesia

 1 
POLA PERSEPAN ANTIBIOTIK PADA PASIEN PNEUMONIA DI POLI ANAK RSUD DR. H. M. ANSARI SALEH BANJARMASIN TAHUN 2017 Muhammad Zaini; Muliyani Muliyani; Jhudi Bonosari Soediono; Elisa Destiana
Jurnal Insan Farmasi Indonesia Vol 2 No 1 (2019)
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Pneumonia was a respiratory infection. Pneumonia was most often caused by bacterial, viral or mycoplasmic infections. The choice of therapy for pneumonia sufferers was generally given antibiotics. The purpose of this study was to determine the pattern of antibiotic use of pneumonia in pediatric patients in outpatient hospitals of dr. H. M. Ansari Saleh. The study was descriptive, data collection was carried out retrospectively in pneumonia patients who met the inclusion criteria was 52 samples. Data was taken from January to December 2017 through medical records. The results showed that pneumonia patients suffered the most from men by 26 cases (50%) and women by 26 cases (50%), based on the age of the most aged 1 - 12 months as many as 25 patients (48.07%). The use of antibiotics based on the selection of the most widely used groups is the third generation cephalosporins as many as 42 patients (80.76%), penicillin group as many as 6 patients (11.53%), the second generation cephalosporins as many as 4 patients (7.69%). The type of antibiotic that was often used is Cefixime as many as 46 users (88.46%), Amoxicillin as many as 6 users (11.53%), Cefadroxyl as many as 4 users (7.69%).
ANALISIS EFEKTIVITAS BIAYA (COST-EFFECTIVENESS) PENGGUNAAN ANTIDIABETES ORAL KOMBINASI PADA PASIEN DIABETES MELITUS TIPE II RAWAT JALAN DI RSUD Dr. H. MOCH. ANSARI SALEH BANJARMASIN Nazhipah Isnani; Muliyani Muliyani; Muhammad Zaini; Muhammad Arif Riyadi
Jurnal Insan Farmasi Indonesia Vol 4 No 1 (2021): Jurnal Insan Farmasi Indonesia
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/jifi.v4i1.683

Abstract

Diabetes melitus merupakan penyakit metabolik kronik, dimana penderita tidak bisa memproduksi insulin dalam jumlah cukup atau tidak mampu menggunakan insulin secara efektif sehingga terjadi hiperglikemi. Terapi DM harus dilakukan sepanjang hidup pasien maka perlu dilakukan analisis efektivitas biaya untuk membantu dalam pengambilan keputusan pemilihan obat yang efektif secara manfaat dan biaya. Penelitian ini bertujuan untuk mengetahui efektivitas biaya terapi kombinasi antidiabetik oral pada pasien Diabetes Melitus tipe II rawat jalan di RSUD Dr. H. Moch Ansari Saleh Banjarmasin. Penelitian ini merupakan penelitian non – ekperimental dengan rancangan deskriptif menggunakan data kualitatif dan desain pendekatan retrospektif. Data yang diambil untuk analisis efektivitas biaya adalah data eketivitas terapi antidiabetik oral dan biaya medik langsung. Hasil dari penelitian ini biaya medik selama 1 bulan terapi yang terkecil adalah kombinasi Glimepiride dan Metformin yaitu ±Rp 125.200,00 dan yang paling terbesar adalah kombinasi Glimepiride dan Pioglitazone yaitu ±Rp345.850,00. Nilai ACER terkecil adalah kombinasi Glimepirid dan Metformin yaitu ±Rp 1.252,00 dan yang paling terbesar adalah kombinasi Glimepiride dan Acarbose yaitu ±Rp 7.737,47. Kesimpulan dari penelitian ini kombinasi antidiabetik oral yang paling cost effectiveness adalah kombinasi Metformin dan Glimepiride dengan Nilai ACER terkecil yaitu ±Rp 1.252,00.
Co-Authors Agung Biworo Amalia Ajrina Desyana Nufus Sholeha Elisa Destiana Hajrah Hidriya Husin Husin JAPERI JAPERI Jhudi Bonosari Soediono Jhudi Bonosari Soediono Khoerul Anwar Lutfan Lazuardi Muhammad Arif Riyadi Muliyani Muliyani muliyani muliyani muliyani, muliyani muliyani Nazhipah Isnani Nazhipah Isnani Nor Jannah Satibi Satibi Vivi Shofia